|
Market Closed -
Saudi Arabian S.E.
08:20:00 2026-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 65.40 SAR | -2.39% |
|
-2.53% | +2.92% |
| 08-27 | Avalon Pharma Reiterated at Overweight as Aljazira Capital Notes 'Solid' Q2 Growth | MT |
| 08-20 | Avalon Pharma Renews SAR50 Million Credit Facility | MT |
Chart: Technical Analysis
Saudi Arabian S.E.SAR
| Markets | Quality | ||
|---|---|---|---|
Saudi Arabian S.E.
| 4016 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 68 | 68 | 78.4 |
| Spread/Res. | -3.82% | -3.82% | -16.58% |
| Spread/Supp. | +3.81% | +5.91% | +17.75% |
| Support | 63 | 61.75 | 55.54 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 4016 Stock
- Charts Middle East Pharmaceutical Industries Company
Select your edition
All financial news and data tailored to specific country editions
